Leucadia launches Sodium Tetradecyl Sulfate injection for varicose veins

Leucadia launches Sodium Tetradecyl Sulfate injection for varicose veins

Leucadia Pharmaceuticals, the commercial sales unit of Custopharm, has launched the FDA-approved Sodium Tetradecyl Sulfate (STS) generic injection in the US. According to Leucadia Pharmaceuticals, the regulated sclerosing agent is therapeutically equivalent to SOTRADECOL and is an effective and safe alternative to the use of unapproved compounded products. Sodium Tetradecyl Sulfate is used for the […]